BAKER BROS. ADVISORS LP

Holdings History for SYNAGEVA BIOPHARMA CORP - COM (GEVA)

Symbol: GEVA
Investment type: Equity / COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2015		-9.5%	$0	0	-11,660,432	-100%		Q2 2015
31 Mar 2015	9.5%	+0.81%	$1,137,242,000	11,660,432	+1,000,000	+9.4%	$97.53	Q1 2015
31 Dec 2014	10%	0%	$989,182,000	10,660,432	0		$92.79	Q4 2014
30 Sep 2014	9.4%	0%	$733,225,000	10,660,432	0		$68.78	Q3 2014
30 Jun 2014	14%	+0.02%	$1,117,213,000	10,660,432	+12,250	+0.12%	$104.80	Q2 2014
31 Mar 2014	11%	+0.4%	$883,480,000	10,648,182	+375,000	+3.7%	$82.97	Q1 2014
31 Dec 2013	9.4%	0%	$664,880,000	10,273,182	0		$64.72	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.